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Objectives and design: This study is a retrospective audit spanning six years following the implementation of a new guideline 
on the management of diabetes in pregnancy. It aims to describe the patient profile of pregnancies complicated by diabetes 
and stillbirth.
Setting: The study was performed in Tygerberg Hospital, Cape Town, a secondary and tertiary referral centre.
Subjects: Fifty-eight pregnancies were complicated by stillbirth (> 500 g). Outcome measures: the patient profile, gestational 
age, co-morbidities, foetal/placental monitoring and avoidable factors were described.
Results: Many patients (32%) booked after 24  weeks’ gestation and missed appointments were common (26.2%). Stillbirths 
ascribed to diabetes constituted 2.3% of all stillbirths at the hospital during the study period. Of the stillbirths 28.1% had Type I 
diabetes mellitus (DM), 64.9% had Type II and 7.0% were in patients with gestational diabetes. The median HbA1c at delivery was 
8.4% (range 6.0–14.1%). In the Type II group, 31 (77.5%) of the stillbirths occurred after 36 weeks, while those among the Type I 
cases ranged from 26 to 38 weeks.
Conclusion: Stillbirths amongst pregnant women with diabetes constituted a small percentage of the total stillbirth burden. 
Emphasising the importance of appropriate antenatal care to women with diabetes and increased surveillance from 36 weeks’ 
gestation may lower the number of stillbirths.
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Introduction
Glucose metabolism changes in pregnancy. Fasting levels of 
serum glucose are decreased while post-prandial levels are 
increased compared with non-pregnant women. Glucose 
tolerance decreases progressively after the first trimester. 
Physiological insulin resistance is brought about by placental 
hormones such as human placental lactogen, glucagon and 
cortisol. Ultimately insulin production is almost doubled to 
maintain euglycaemia. Gestational diabetes mellitus (GDM) 
develops when there is a mismatch between this increased 
insulin demand and the ability of the maternal pancreas to 
appropriately increase its production of insulin, due to a reduced 
beta-cell reserve. This also explains the increased therapy 
requirements of established (pre-gestational) diabetes.
The incidences of both Type II diabetes mellitus (DM) and GDM 
are rising. This can be attributed first to the pregnant population 
becoming older and more obese. Rising levels of obesity that 
correspond with high-calorie diets and decreased levels of 
physical activity affect many countries, including South Africa.1,2 
Furthermore, the diagnostic thresholds for the diagnosis of GDM 
have been lowered following the sentinel ACHOIS and HAPO 
studies, which showed composite benefit by initiating 
intervention at lower glucose levels.3–5
The management of patients with diabetes in pregnancy at 
Tygerberg Hospital has previously been carefully described and 
the guidelines are on a par with international recommendations.6–8
All inborn perinatal deaths at Tygerberg Hospital are discussed at 
a weekly, multidisciplinary meeting. Apart from a primary cause 
of death, associated patient-related, medical and administrative 
avoidable factors are identified. Unlike true GDM, pre-gestational 
diabetes is associated with the complication of sudden 
unexplained intra-uterine death (IUD). This audit was performed 
to re-examine the stillbirths related to maternal diabetes and 
determine the timing and factors associated with this outcome.
Materials and methods
This study was a retrospective audit spanning a six-year period 
that followed implementation of a new Tygerberg Hospital 
guideline on the management of diabetes.7 Patients included 
were managed at Tygerberg Hospital, a combined secondary/
tertiary referral unit in Cape Town, South Africa, where all 
perinatal deaths are discussed and entered into the national 
Perinatal Problem Identification Program (PPIP) database.
The diagnosis of pre-gestational diabetes (Type I or II) was made 
when the history was known. Gestational diabetes was regarded 
as any new onset hyperglycaemia in pregnancy. The precise 
diagnostic criteria (based on the NICE guidelines) are contained 
in the provincial guideline on diabetes mellitus in pregnancy 
(Western Cape), which has been fully described in a recent 
publication.7 Care was taken to differentiate this from 
undiagnosed pre-gestational diabetes (i.e. when any one of the 
WHO Criteria for overt DM were met), although this differentiation 
was not always possible. A stillbirth was defined as asystole in a 
newborn of > 500 g birth weight. Viability was set at 27 weeks’ 
gestation. The gestational age at diagnosis of the intra-uterine 
death was used for each pregnancy. Delivery was offered as 
standard practice at 38  weeks’ gestation.7 The principal 
investigator retrieved the records and re-linked the file numbers 
to all diabetes-associated stillbirths over six years. File records 
were then scrutinised using a data sheet with study numbers 
only.
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Data were analysed using standard IBM SPSS® version 24 (IBM 
Corp, Armonk, NY, USA). Descriptive statistics were used to 
describe the data. For continuous variables, the results are 
expressed in terms of means, standard deviations, medians and 
ranges. Frequency tables (n, %) were used to describe some 
categorical variables.
The study was approved and registered by the Human Research 
Ethics Committee of the Faculty of Medicine and Health Sciences, 
Stellenbosch University (S15/08/185). A waiver of consent was 
granted for this retrospective audit.
Results
This study was conducted from Janury 1, 2010 to December 31, 
2015 during which time a total of 59 stillbirths (including one set 
of twins) were attributed to DM. These 59 stillbirths constituted 
2.3% of all stillbirths and 0.14% of the 43 095 births (> 500  g) 
during the study period.9 The maternal characteristics at study 
entry are shown in Table 1.
After re-examination of factors known to be associated with 
stillbirth, patients were sub-divided into the following groups 
according to the gestational age at diagnosis of the stillbirth (58 
patients had available information). Selected pertinent facts are 
reported in Table 2.
Four patients (6.9%) were known to have human 
immunodeficiency virus. Three of these patients were using anti-
retroviral therapy and one used peri-partum prophylaxis prior to 
long-term anti-retroviral therapy becoming the standard 
management in pregnancy. The classification of deaths in the 
different categories of DM is depicted in Table 3.
Thirty-one (77.5%) of the deaths amongst the Type II group 
occurred after 36w0d, while those among the Type I cases ranged 
from 26 weeks to 38 weeks’ gestation. Treatment regimens are 
categorised in Table 4.
Long-term glucose control was monitored using glycosylated 
haemoglobin (HbA1c). A pre-gestational HbA1c was available in 
nine patients (median 9.2%, range 7.5–11.6). The median 
booking HbA1c value (n = 45) was 8.3% (range 5.9–12.0%) and 
the median pre-delivery value (n = 45) was 8.4% (range 6.0–
14.1%).
A foetal abnormality (including growth aberrations) was noted in 
20 (40%) babies on either antenatal ultrasound or post-natal 
examination. These are depicted in Table 5. Birth weights for five 
babies met the criteria for small-for-gestational-age. The birth 
weights for four (7.1%) babies plotted below the 10th centile and 
one baby had a weight below the 3rd centile. The gestational 
ages of these 5 babies ranged from 28w1d to 40w5d. Macerated 
babies were noted in 48 cases (85.7%). In 21 (65.6%) of the 31 
patients with available placental histology, diabetic changes 
were detected.
Discussion
Stillbirths ascribed to diabetes mellitus are a matter of concern 
to obstetricians worldwide. International data from an audit on 
pregnancy outcomes in diabetic patients in the United Kingdom 
estimated the stillbirth rate to be 12.8 per 1 000 births to all 
women with diabetes.10 Stillbirths are generally associated with 
pre-gestational diabetes and not with true GDM, but precise 
classification may be challenging due to several confounding 
factors. However, it is particularly important to detect 
undiagnosed pre-gestational diabetes in pregnancy as the risk 
profile differs for the mother and the foetus.
Available data for South Africa come from two publications. In 
2005 Huddle published an 11-year audit of the outcomes of 
pregnancy in diabetic women in Soweto.11 He noted 2.8% 
stillbirths amongst women with GDM as well as 3.9% and 1.8% 
stillbirths in women with Types I and II diabetes respectively. A 
more recent publication by Hall et al. from Tygerberg Hospital, 
Cape Town found no stillbirths amongst women with Type I 
diabetes, as well as 6.5% and 12% stillbirths amongst women 
with Types II and gestational diabetes respectively.6 The latter 
study covered only 12 months and less attention was given to 
differentiating undiagnosed pre-gestational diabetes from true 
GDM.
In the index study an accurate number of all pregnancies 
managed with diabetes could not be obtained from the various 
clinics where the audit was performed. When expressed as a 
stillbirth rate for all births > 500 g from 2010 to 2015 the figure 
was 1.39/1 000. Once broken down into annual rates over the 
six-year period, the figure varied from 0.89/1 000 to 2.12/1 000.9 
The stillbirth rate may be overrepresented in these figures due to 
the fact that the study hospital serves as a secondary and tertiary 
referral centre.
A pregnant patient with diabetes carries an increased risk of 
stillbirth due to multiple factors. For this reason, women with 
diabetes who are contemplating pregnancy should be well 
educated concerning pre-conception glycaemic control and 
folate supplementation, early booking for antenatal care and 
meticulous compliance with the care-plan. In this study 11% of 
patients had experienced a previous pregnancy loss (from any 
cause), 32% booked late (≥ 24  weeks’ gestation) for care 
and  >  50% denied clinicians an adequate opportunity to 
intervene meaningfully. The gestation-dependant relative risk 
increases as follows: RR 4.95 (95% CI 2.61–2.84) at 32–34 weeks, 
3.77 (95% CI 3.42–4.16) at 35–36 weeks, 5.75 (95% CI 5.43–6.09) 
Table 1: Maternal characteristics at study entry (data as median/range 
or n/%)
*Information was not available for all 59 patients.
Age (years) (n = 57)* 31 (17–44)
Gravidity (n = 57)* 3 (1–11)
Parity (n = 57)* 3 (0–11)
Body mass index kg/m2 (n = 48)*





> 50.1 5 (10.4)
Chronic hypertension (n = 56)* 15 (26.7)
Any previous pregnancy loss ≥ 24 weeks (n = 56)* 8 (14.3)
Previous pregnancy loss ≥ 24 weeks due to diabetes  
(n = 56)*
3 (5.4)
Previous baby ≥ 4 kg (n = 50)* 4 (8.0)
Gestation at booking (weeks) (n = 50)* 17 (5–38)
Booked < 24w0d (n = 50)* 34 (68.0)
Gestation at entry to appropriate level of care (n = 53)* 26 (6w0d–40w0d)
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at 37–38  weeks to 7.34 (95% CI 6.52–8.25) at 39  weeks and 
more.12 In the index study half of the stillbirths were diagnosed 
after 37  weeks. Surveillance should therefore be increased 
around this time and in accordance with the NICE guidelines 
delivery planned at 38 weeks’ gestation or earlier if indicated.13 
Correct patient selection for earlier delivery remains a clinical 
challenge, especially in the context of a resource-constrained 
neonatal service and known respiratory morbidity.
Table 2: Gestation-specific analysis*
*Patients may have more than one complication.
1This patient suffered from severe target-organ involvement that included peripheral neuropathy, a forefoot amputation, nephropathy and cardiomyopathy with a left 
ventricular ejection fraction < 20%. This patient consented to a medical termination of pregnancy at 23 weeks’ gestation.
2This includes one twin pregnancy.
3This practice is in accordance with the Provincial Guideline of the Western Cape (refer to reference7).
4This foetus developed absent end-diastolic flow in the umbilical artery at 31 weeks’ gestation and declined in-patient management. Upon her return two days later, foetal 
distress was diagnosed and despite an emergency Caesarean section the baby was stillborn.
5No HbA1C was available to discern between GDM and Type II DM.
6This group includes three patients with absent notes referred from the private sector.
Factor < 27w0d 
n = 3 
5.2%
27w0d-31w6d 
n = 10 
17.2%
32w0d-33w6d 
n = 2 
3.4%
34w0d-35w6d 
n = 4 
6.9%
36w0d-37w6d 
n = 16 
27.6%
38w0d-38w6d 







Type I 11 5 1 3 3 3











1 3 1 3 1
Hypertension:




Not performed3 5 8 4 4
Abnormal 14
Patient-avoidable factors:
Unbooked 1 2 1 2
Booked > 
24 weeks
3 1 4 3 3
Missed appoint-
ments















Delayed diagnosis 1 2 2
Delayed referral6 1 1 1 2 4
Table 3: Classification of deaths according to type of diabetes in 
pregnancy
Note: Patients with available information: n = 57.
Factor n (%)
Type I 16 (28.1)
Type II 37 (64.9)
Gestational diabetes 4 (7.0)
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glucometers for home monitoring themselves, while the 
government funds the test strips.
The authors believe that, ideally, multidisciplinary centres of 
excellence should be established for the treatment of pregnant 
women with diabetes. These centres should be accessible and 
would include a maternal-foetal subspecialist, endocrinologist, 
dietician, diabetic educator and nurse practitioners, all with 
specific interests and experience in managing diabetes in 
pregnancy. Offering a single point of care will help address many 
of the administrative, medical and certain patient-avoidable 
factors highlighted in this study. This would facilitate streamlining 
of referrals to appropriate levels of care, aid with standardisation 
of assessment and monitoring of mother and foetus and ease 
ongoing education, tailored medical nutrition therapy and 
support of the patients. Where this is not available, medical staff 
at all levels should be familiar with and apply local protocols 
drafted by experts.
Although the numbers of pregnant women with diabetes are 
rising, stillbirths in this group constituted only a small percentage 
of the total stillbirth burden. In most of these cases clinicians 
were denied an adequate opportunity to intervene meaningfully. 
Better education of women with diabetes and increased 
surveillance from 36  weeks’ gestation may further lower the 
number of stillbirths.
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